Introduction
Glioma, one of the frequently detected primary brain tumors in adults has around 3 months of median survival in patients availing no treatment (Ng et al., 2007) . The rapid rate of proliferation, invasion and metastasis in combination with poor prognosis demand for the novel treatment strategies (Lin et al., 2008; PaezRibes et al., 2009) . Therefore, researchers are investigating the various signaling pathways in order to develop therapeutic agents to treat the glioma (Gan et al., 2009; Jang et al., 2008) .
Survival and proliferation of tumor cells are regulated by the members of signal transducer and activator of transcription (STAT) protein family, including STAT3 (di Tomaso et al., 2009) . In various types of carcinoma cells, STAT3 is found to be present in higher level (Darnell, 2002; Buettner et al., 2002) . The Janus activated kinase, JAK2 also plays an important role in the activation of STAT3 (Ihle, 1996; Ren and Schaefer, 2002) . Phosphorylation of STAT3 induces the expression of genes involved in cell proliferation, survival and angiogenesis (Gao and Bromberg, 2006) .
Retinoic acid exhibits inhibitory effect on the colon cancer (Zheng et al., 1999) , prostate cancer (Liang et al., 1999) and lung cancer (Weber et al., 1999) . Retinoic acid has also been shown to be of vital importance in the treatment of recurrent malignant cerebral gliomas (Yung et al., 1994) . Some of the promising effects of retinoic acid treatment in human malignant gliomas anti-proliferation, anti-migration and anti-invasive activity (Bouterfa et al., 2000; Rotan, 1991) . The present study
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12 Inhibition of cell proliferation by 2-fluorobenzaldehyde retinoic acid conjugate through suppression of STAT3 activation in human glioma cells was aimed to investigate the effect of 2-fluorobenzaldehyde retinoic acid conjugate (Figure 1 ) on the proliferation, STAT3 activation, and expression of pro-apoptotic, anti-apoptotic and angiogenesis genes in glioma cells.
Materials and Methods

Reagents
Retinoic acid, bovine serum albumin and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide were obtained from Sigma-Aldrich (USA). 2-florobenzaldehyde retinoic acid conjugate (RAC) stock solution (20 mmol/L) was prepared in dimethyl sulfoxide and stored at 0ºC.
Synthesis of retinoic acid chalcone
Retinoic acid was oxidized with Dess Martin periodinane (DMP) in dichloromethane at room temperature. The oxidized product was treated with KOH (1 eq) and 2-florobenzaldehyde (1 eq) at 70ºC to afford the desired product, 2-florobenzaldehyde retinoic acid conjugate (Scheme 1).
Cell culture and cell viability assay
Human glioma cell line, U373 was obtained from American Type Culture Collection (ATCC, USA). The cells were cultured in Dulbecco's modified Eagle's medium (USA) containing 10% fetal bovine serum and antibiotics at 37ºC in humidified atmosphere of 5% CO2.
Cell proliferation assay
U373 glioma cells at a density of 3 x 10 5 cells per well were distributed onto 96-well plates and cultured overnight. The cells were treated with various concentrations of 2-fluorobenzaldehyde retinoic acid conjugate for 24 hours. The effect on cell proliferation was determined using BrdU assay kit (Roche Diagnostics, Germany). Incubation with the reagent was performed according to the manufacturer's instructions. Absorbance for each well of the plate was measured at 455 nm using spectrometer.
Western blotting
U373 glioma cells were incubated with various concentration of 2-fluorobenzaldehyde retinoic acid conjugate or DMSO as control for 48 hours. The cells were washed twice with ice-cold PBS followed by lysis in 1x RIPA lysis buffer for 20 min. For the determination of protein concentration in the cell lysate protein assay (Bio-Rad, Hercules, CA, USA) was used. The lysates were resolved on SDS-PAGE and then transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, USA). Incubation of the membranes was performed overnight with primary antibodies polyclonal rabbit anti-human β-actin, antibodies against STAT, survivin, Bcl-2, Bcl-xL, cyclin D1, VEGF, and caspase-3 antibodies (Danvers, USA). The membranes after washing with PBS were incubated with anti-mouse or anti-rabbit horseradish peroxidase-conjugated IgG (Promega Corporation). The Western Lightning® Plus enhanced chemiluminescence (ECL) substrate (PerkinElmer) and autoradiography was used for visualization of protein expression. The densitometric analysis of X-ray films was performed with Alpha Imager System (ProteinSimple, Santa Clara, CA, USA) using Alpha View software.
Determination of apoptosis in U373 cells
Analysis of apoptosis in U373 glioma cells was performed by using annexin V-FITC apoptosis detection kit (MBL) and propidium iodide stain. U373 cells seeded on tissue culture slides were allowed to attach for 24 hours followed by treatment with 2-fluorobenzaldehyde retinoic acid conjugate for 48 hours. The cells were treated with 1x binding buffer (200 μL), annexin V-FITC (5 μL) and propidium iodide (5 μL). Following incubation under dark conditions for 5 min at 37ºC, fluorescent microscopy (BD FacsCalibur) was used to analyze the number of viable and apoptotic cells. 
Analysis of cell cycle
The tissue culture flasks (T-75 flask; Nunc A/S) containing RPMI-1640 medium supplemented with 2% FBS were seeded with U373 glioma cells at a density of 3 x 10 6 cells per flask. The cells were incubated for 24 hours with various concentrations of 2-fluorobenzaldehyde retinoic acid conjugate, washed twice with ice-cold PBS buffer and fixed in 70% ice-cold ethanol. Centrifugation of the contents from each of the flask was performed at 15000 xg for 15 min. The cells were washed with PBS and treated with 100 μL PBS supplemented with 1 mM RNase A (Qiagen, Hilden, Germany) for 1 hour at 37ºC. After incubation, the cells were subjected to propidium iodide (50 μg/mL; Sigma-Aldrich) staining for 20 min. FACSV antage SE flow cytometry system and cell quest program (BD Biosciences) were used to analyze the DNA content after cells were filtered through a 40 μm nylon mesh (BD Biosciences, USA).
Statistical analysis
All the data expressed are the mean ± SD. One-way ANOVA was used for the analysis of the data obtained and comparisons were made using Mann-Whitney U test. p-value<0.05 was considered statistically significant in all the cases.
Results
Inhibition of U373 glioma cell proliferation
The results from BrdU assay revealed that 2-fluorobenzaldehyde retinoic acid conjugate exhibited inhibitory effect on cell proliferation in U373 glioma cells in a dose and time-dependent manner. Increase in the concentration of 2-fluorobenzaldehyde retinoic acid conjugate from 10-50 µM, reduced the viability of U373 cells from 98 to 19% after 48 hours. The proportion of viable cells at 6, 12, 24, 36 and 48 hours following treatment with the compound were 96, 81, 76, 43 and 19%, respectively (Figure 2) .
Inhibition of constitutive STAT3 activation
The results from Western blot analysis revealed that 2-fluorobenzaldehyde retinoic acid conjugate inhibited the activation of STAT3 in U373 cells. Inhibition of STAT3 in U373 cells was significant at 50 µM concentration of RAC after 3 hours, without any effect on STAT3 protein (Figure 3) . Treatment of U373 cells with AG490 (50 µmol/L), inhibitor of JAK2-STAT3 activation inhibited STAT3 phosphorylation similar to 2-fluorobenzaldehyde retinoic acid conjugate (Figure 3) .
Inhibition of inducible JAK2 phosphorylation
Treatment of U373 cells with IL-6 significantly induced phosphorylation of JAK2 after 15 min. However, when U373 cells were pretreated with RAC followed by IL-6 treatment a marked reduction in the phosphorylation of JAK2 was observed after 2 hours (Figure 4 ).
Effect on expression of Bax and Bak proteins and antiapoptotic gene
Analysis of the effect of 2-fluorobenzaldehyde retinoic acid conjugate on the expression of Bax and Bak proteins in U373 glioma cells revealed a significant increase after 24 hours ( Figure 5A ). RAC treatment caused a marked reduction in the expression of cyclin D1, Bcl-2, BclxL, survivin and VEGF in U373 cells after 24 hours ( Figure  5B ). In addition, the expression of Mcl-1 was also inhibited by RAC after 24 hours in U373 cells ( Figure  5C ).
Effect on cell cycle distribution
Analysis of cell cycle distribution revealed a marked increase in the population of cells in G1 phase on RAC treatment after 24 hours. On the other hand, RAC treatment for 48 hours led to a significant increase in the population of cells in sub-G1 phase (Figure 6 ). 
Discussion
The present study was performed to investigate the anticancer effects of 2-fluorobenzaldehyde retinoic acid conjugate through inhibition of STAT3 signaling pathway in glioma cells. It was observed that RAC treatment inhibited the phosphorylation of constitutive as well as IL-6 induced STAT3. The expression of proapoptotic genes, including cyclin D1, survivin, Bcl-2, Bcl -xL, Mcl-1 and VEGF was inhibited by 2-fluorobenzaldehyde retinoic acid conjugate. Moreover, the population of glioma cells in G1-G0 phase was increased indicating the induction of apoptosis.
It is reported that AG490, a potent inhibitor of JAK2 inhibits the phosphorylation of STAT3 at a concentration of 50 µmol/L (Bharti et al., 2003) . The results from the present study showed that RAC inhibited the activation of STAT3 at a concentration of 40 µM after 3 hours in glioma cells. 2-Fluorobenzaldehyde retinoic acid conjugate treatment exhibited no influence on the expression of STAT3 protein. Phosphorylated STAT3 inhibits the induction of apoptosis in carcinoma cells and thereby promotes the process of oncogenesis . The enhanced resistance to apoptosis by activated STAT3 is believed to be mediated by the increased expression of anti-apoptotic genes, Bcl-2 and cyclin D1 (Danial et al., 1995) . Our results demonstrated that 2-fluorobenzaldehyde retinoic acid conjugate inhibited the expression of cyclin D1, proliferative gene; survivin, Bcl-2, Bcl-xL, and Mcl-1, antiapoptotic gene and VEGF, angiogenic genes. The progression of cell cycle from G1 to S phase in the cells is mediated by the expression of cyclin D1 (Niu et al., 1999) . In the carcinoma cells Bcl-xL is expressed in higher concentration and its expression is induced by activation of STAT3 (Niu et al., 1999) . The role of Bcl-xL is to prevent the 
